Sysmex Europe
Menu

RNXtract® for MammaTyper®

RNXtract® Nucleic Acid Extraction Kit 

RNXtract® is intended for routine clinical use for extraction and purification of total nucleic acid from formalin-fixed and paraffin-embedded (FFPE) sample material. 

The kit includes eight reagent vials supporting 48 extractions and is validated for use with the MammaTyper® assay.

More details

Graphical Representation of the Procedure

RNXtract® Nucleic Acid Extraction Kit overview:

  • Purifies nucleic acids from FFPE samples
  • Magnetic bead–based binding ensures efficient nucleic acid isolation with high purity and yield.
  • Optimized washing removes proteins, nucleases, and impurities for high purity
  • No deparaffinization step is required making the process user-safe and environmentally friendly.
  • No plastic columns used → reduces nucleic acid loss during purification

 

Supporting literature:

Varga Z, Lebeau A, Bu H, Hartmann A, Penault-Llorca F, Guerini-Rocco E, Schraml P, Symmans F, Stoehr R, Teng X, Turzynski A, von Wasielewski R, Gürtler C, Laible M, Schlombs K, Joensuu H, Keller T, Sinn P, Sahin U, Bartlett J, Viale G. An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®. Breast Cancer Res. 2017 May 11;19(1):55. doi: 10.1186/s13058-017-0848-z. PMID: 28490348; PMCID: PMC5426065.

Laible M, Schlombs K, Kaiser K, Veltrup E, Herlein S, Lakis S, Stöhr R, Eidt S, Hartmann A, Wirtz RM, Sahin U. Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens. BMC Cancer. 2016 Jul 7;16:398. doi: 10.1186/s12885-016-2476-x. PMID: 27389414; PMCID: PMC4936300.

Gürtler C, Laible M, Schwabe W, Steinhäuser H, Li X, Liu S, Schlombs K, Sahin U. Transferring a Quantitative Molecular Diagnostic Test to Multiple Real-Time Quantitative PCR Platforms. J Mol Diagn. 2018 Jul;20(4):398-414. doi: 10.1016/j.jmoldx.2018.02.004. Epub 2018 Apr 3. PMID: 29625248.

Technical specifications
Feature RNXtract® Nucleic Acid Extraction Kit
Sample type 10 uM FFPE tissue section (tumor cell content >20 %)
Sample capacity 48 extractions
Product Classification IVDD
Technology Binding of nucleic acids to magnetic beads
Elution Volume 100 µL
Extraction Time Approximately 2.5 hours
Final Product Total Nucleic Acid
Pre-deparaffinization of FFPE Not required
Storage Conditions Stable at room temperature for up to 12 months
Catalogue Number CC01011

 

References

  1. Wirtz RM et al., Breast Cancer Res Treat 2016; 157(3), 437446
  2. Varga Z et al., Breast Cancer Res 2017; 19(55), 1-13
  3. Caselli E et al., PLOS ONE 2021; 16(9), 1-18
  4. Shaaban A et al., Eur J Cancer 2022; 175(1), 87-88
Contact us
You have a question and would like to get in touch with our experts? We look forward to receiving your enquiry.

Sysmex Europe SE

Deelböge 19 D

22297 Hamburg

Germany

+49 (40) 527 26 0

+49 (40) 527 26 100

Explore more

MammaTyper®

MammaTyper®

Comprehensive molecular subtyping of breast cancer patients

Details
RD-210

RD-210

OSNA gene amplification detector

Details
CytoCell® IVDR FISH probes

CytoCell® IVDR FISH probes

IVDR-certified FISH probes 

Details
Copyright © Sysmex Europe SE. All rights reserved.